Heterocyclic acridone inhibitors of IMPDH enzyme

   
   

Compounds having the formula (I), ##STR1##

wherein R3 is selected from H, OH and NH2; R30 is selected from O and S; W is -C(O)-, -S(O)-, or -S(O)2-; or W may be -CH2- if X is -C(O)-; X is selected from -CH2-, -N(R4)-, and -O-, except that when W is -CH2-, X is -C(O)-; Y is a bond or -C(R40)(R45)-; Q is a linker; Z is optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, or heterocyclyl; and X1, X2, X3, X4, X5, X6, X7, X8, X9, X10 and X11 are selected such a tricyclic heteroaryl ring system is formed as further defined in the specification.

 
Web www.patentalert.com

< Gene coding for heliomicine and use thereof

< Keratinocyte growth factor-2

> Methods of treating cytokine mediated diseases

> Preparations and use of an Ah receptor ligand, 2-(1H-indole-3-carbonyl)-thiazole-4-carboxylic acid methyl ester

~ 00193